Gul Kaplan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gul Kaplan has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Aysun Tekeli Taşkömür
Department of Gynecology and Obstetrics, Amasya University Faculty of Medicine, Amasya, Turkey
1 shared publication - Ecem Kaya-Sezginer
Department of Biochemistry Faculty of Pharmacy, Ankara University Ankara Türkiye
1 shared publication - Fatma Zeynep Kırlangıç
AMASYA UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF SURGICAL MEDICAL SCIENCES, DEPARTMENT OF MEDICAL PATHOLOGY
1 shared publication - Fugen Aktan
Department of Biochemistry, Faculty of Pharmacy, Ankara University, Ankara, Turkey
1 shared publication - Omer Faruk Kirlangic
Vocational School of Health , Ankara University , Ankara , Türkiye
1 shared publication - Taner Ozgurtas
Department of Biochemistry, Gulhane Military Medical Academy, Ankara, Turkey
1 shared publication
Latest Publications
- Open Access
- 30 January 2024
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 49 (2) , 266-273
Vascular endothelial growth factor (VEGF)-C and its receptors, soluble VEGFR-2 and VEGFR-3, in polycystic ovary syndrome
Objectives: Angiogenesis is involved in polycystic ovary syndrome (PCOS) progression. Vascular endothelial growth factor-C (VEGF-C) and its receptors are key angiogenic markers. The main objective of this study was to investigate the serum levels of VEGF-C and its receptors, soluble VEGF receptor 2 (sVEGFR-2) and VEGFR-3, in patients with PCOS and healthy controls and determine the link between serum levels of these VEGF-related proteins and the biochemical and hormonal data of patients with PCOS. Methods: Thirty-six women with PCOS and 30 controls were included in this study. The measurement of VEGF-C, sVEGFR-2, and VEGFR-3 levels in serum and routine biochemical and hormone analysis were performed. Results: In the PCOS group, significantly higher serum sVEGFR-2 levels and no significant differences in serum VEGF-C and VEGFR-3 were observed compared to the controls. Serum sVEGFR-2 levels exhibited positive associations with VEGF-C, VEGFR-3, total cholesterol, and anti-müllerian hormone (AMH) in women with PCOS. Moreover, a positive correlation between serum VEGF-C and VEGFR-3 concentrations was detected in patients with PCOS. The cutoff value of serum sVEGFR-2 was 4.24 ng/mL (sensitivity 68 %, specificity 64 %) to distinguish PCOS. Conclusions: Despite unaltered levels of serum VEGF-C and VEGFR-3, there was an association between circulating levels of sVEGFR-2 and these VEGF-related proteins. sVEGFR-2 could be a promising diagnostic biomarker for PCOS. Regarding the significant correlation between sVEGFR-2 and AMH, sVEGFR-2 could have an impact on the hormonal elements of PCOS. Further studies are warranted to fully understand the function of VEGF-C and its receptors in PCOS.
- 30 January 2024
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 49 (2) , 266-273
Open AccessVascular endothelial growth factor (VEGF)-C and its receptors, soluble VEGFR-2 and VEGFR-3, in polycystic ovary syndrome
Objectives: Angiogenesis is involved in polycystic ovary syndrome (PCOS) progression. Vascular endothelial growth factor-C (VEGF-C) and its receptors are key angiogenic markers. The main objective of this study was to investigate the serum levels of VEGF-C and its receptors, soluble VEGF receptor 2 (sVEGFR-2) and VEGFR-3, in patients with PCOS and healthy controls and determine the link between serum levels of these VEGF-related proteins and the biochemical and hormonal data of patients with PCOS. Methods: Thirty-six women with PCOS and 30 controls were included in this study. The measurement of VEGF-C, sVEGFR-2, and VEGFR-3 levels in serum and routine biochemical and hormone analysis were performed. Results: In the PCOS group, significantly higher serum sVEGFR-2 levels and no significant differences in serum VEGF-C and VEGFR-3 were observed compared to the controls. Serum sVEGFR-2 levels exhibited positive associations with VEGF-C, VEGFR-3, total cholesterol, and anti-müllerian hormone (AMH) in women with PCOS. Moreover, a positive correlation between serum VEGF-C and VEGFR-3 concentrations was detected in patients with PCOS. The cutoff value of serum sVEGFR-2 was 4.24 ng/mL (sensitivity 68 %, specificity 64 %) to distinguish PCOS. Conclusions: Despite unaltered levels of serum VEGF-C and VEGFR-3, there was an association between circulating levels of sVEGFR-2 and these VEGF-related proteins. sVEGFR-2 could be a promising diagnostic biomarker for PCOS. Regarding the significant correlation between sVEGFR-2 and AMH, sVEGFR-2 could have an impact on the hormonal elements of PCOS. Further studies are warranted to fully understand the function of VEGF-C and its receptors in PCOS.